Human T Cells Engineered to Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity

Journal of Immunology - United States
doi 10.4049/jimmunol.1203085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

miR-28 Modulates Exhaustive Differentiation of T Cells Through Silencing Programmed Cell Death-1 and Regulating Cytokine Secretion

Oncotarget
Oncology
2016English

Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Mechanisms for Enhanced Antitumor Immune Responses Induced by Irradiated Hepatocellular Carcinoma Cells Engineered to Express Hepatitis�B Virus X Protein

Oncology Letters
Cancer ResearchOncology
2018English

Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma

Archives of Dermatology
2010English

Expression of Programmed Death 1 Ligands by Murine T Cells and APC

Journal of Immunology
AllergyImmunology
2002English

Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

English

Programmed Death-1 Impairs Secondary Effector Lung CD8+T Cells During Respiratory Virus Reinfection

Journal of Immunology
AllergyImmunology
2014English

Engineered T Cells Bypass Death Signaling and Bolster Immunotherapy

Cancer Discovery
Oncology
2019English

Enhanced Antitumor Activity of Cerulenin Combined With Oxaliplatin in Human Colon Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy